欧普康视：盐酸毛果芸香碱滴眼液药物临床试验获批

Core Viewpoint - The company, Opcon Vision (300595), has received approval from the National Medical Products Administration for clinical trials of its drug, "Pilocarpine Hydrochloride Eye Drops," aimed at treating presbyopia in adults [1] Group 1 - The company announced the receipt of the clinical trial approval notice on December 5 [1] - The approved indication for the drug is specifically for the treatment of presbyopia in adults [1]